Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Stanton

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
European Journal of Preventive Cardiology|October 6, 2012
Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE): rationale and design of a randomised controlled trial of a cardiovascular preventive polypill-based strategy in India and EuropeSimon Thom, Jane Field, Neil Poulter, et al.
Contemporary Clinical Trials|July 11, 2016
An open-label randomized-controlled trial of low dose aspirin with an early screening test for pre-eclampsia and growth restriction (TEST): Trial protocolFionnuala Mone, Cecilia Mulcahy, Peter McParland, et al.
Diabetes Care|February 27, 2009
Serum amyloid A, C-reactive protein, and retinal microvascular changes in hypertensive diabetic and nondiabetic individuals: an Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) substudyChristoph Stettler, Nicholas Witt, Robyn J Tapp, et al.
JAMA|September 5, 2013
Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trialSimon Thom, Neil Poulter, Jane Field, et al.
Diabetes Care|January 11, 2008
Retinal vascular lesions in patients of Caucasian and Asian origin with type 2 diabetes: baseline results from the ADVANCE Retinal Measurements (AdRem) studyRonald P Stolk, Mary J van Schooneveld, J Kennedy Cruickshank, et al.
Hypertension (Dallas, Tex. : 1979)|November 13, 2013
Long-term antihypertensive treatment fails to improve E/e' despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudyAnthony J Barron, Alun D Hughes, Andrew Sharp, et al.
Open Heart|February 4, 2025
Tissue Doppler echocardiography predicts long-term cardiovascular mortality: the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) legacy 20-year follow-up studyAnenta Ratneswaren, Tong Wu, Amit Kaura, et al.
Hypertension (Dallas, Tex. : 1979)|May 14, 2014
Excess pressure integral predicts cardiovascular events independent of other risk factors in the conduit artery functional evaluation substudy of Anglo-Scandinavian Cardiac Outcomes TrialJustin E Davies, Peter Lacy, Therese Tillin, et al.
Nutrition Research Reviews|June 3, 2025
Sustainable and available sources of omega-3 fatty acids for health: are the current dietary recommendations, food sources and legislation fit for purpose?Eva Lewis, Simon Steenson, Richard P Haslam, et al.
European Journal of Human Genetics : EJHG|November 1, 2007
An assessment of the Irish population for large-scale genetic mapping studies involving epilepsy and other complex diseasesColm T O'Dushlaine, Ciara Dolan, Michael E Weale, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
European Journal of Preventive Cardiology|October 6, 2012
Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE): rationale and design of a randomised controlled trial of a cardiovascular preventive polypill-based strategy in India and EuropeSimon Thom, Jane Field, Neil Poulter, et al.
Contemporary Clinical Trials|July 11, 2016
An open-label randomized-controlled trial of low dose aspirin with an early screening test for pre-eclampsia and growth restriction (TEST): Trial protocolFionnuala Mone, Cecilia Mulcahy, Peter McParland, et al.
Diabetes Care|February 27, 2009
Serum amyloid A, C-reactive protein, and retinal microvascular changes in hypertensive diabetic and nondiabetic individuals: an Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) substudyChristoph Stettler, Nicholas Witt, Robyn J Tapp, et al.
JAMA|September 5, 2013
Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trialSimon Thom, Neil Poulter, Jane Field, et al.
Diabetes Care|January 11, 2008
Retinal vascular lesions in patients of Caucasian and Asian origin with type 2 diabetes: baseline results from the ADVANCE Retinal Measurements (AdRem) studyRonald P Stolk, Mary J van Schooneveld, J Kennedy Cruickshank, et al.
Hypertension (Dallas, Tex. : 1979)|November 13, 2013
Long-term antihypertensive treatment fails to improve E/e' despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudyAnthony J Barron, Alun D Hughes, Andrew Sharp, et al.
Open Heart|February 4, 2025
Tissue Doppler echocardiography predicts long-term cardiovascular mortality: the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) legacy 20-year follow-up studyAnenta Ratneswaren, Tong Wu, Amit Kaura, et al.
Hypertension (Dallas, Tex. : 1979)|May 14, 2014
Excess pressure integral predicts cardiovascular events independent of other risk factors in the conduit artery functional evaluation substudy of Anglo-Scandinavian Cardiac Outcomes TrialJustin E Davies, Peter Lacy, Therese Tillin, et al.
Nutrition Research Reviews|June 3, 2025
Sustainable and available sources of omega-3 fatty acids for health: are the current dietary recommendations, food sources and legislation fit for purpose?Eva Lewis, Simon Steenson, Richard P Haslam, et al.
European Journal of Human Genetics : EJHG|November 1, 2007
An assessment of the Irish population for large-scale genetic mapping studies involving epilepsy and other complex diseasesColm T O'Dushlaine, Ciara Dolan, Michael E Weale, et al.
Pageof 7